Medicines Partnership
The week in review
This week, all eyes have been on the King Review interim report, as stakeholders released their formal responses Most stakeholders, it’s fair to say, weren’t thrilled with the Interim Report …
Stakeholders reject Interim Report options
Members of the Medicines Partnership of Australia have banded together to raise concerns about the future stability of pharmacy The stakeholders, which include the Guild, PSA, ASMI, Generic and Biosimilar …
Interim report ‘a step backwards’
Peak bodies have come together to highlight potential problems with King Review suggestions Members of the Medicines Partnership of Australia, the nation’s pharmaceutical supply chain peak body, have expressed concern …
PBS sustainability proven, more cuts unnecessary: Medicines Partnership
The sustainability of the PBS has been highlighted by the release of Productivity Commission data which puts the cost of the PBS per person at a 10 year low, says …
PBS spending declining, Rx volume under control
Government spending on the PBS per head of population has been in decline for almost three years, reinforcing the sustainability of the current scheme, the Medicines Partnership Australia says. The …